
2Eyes Vision
Visual simulation technologies for presbyopia and cataract surgery.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | €2.0m | Seed | |
Total Funding | 000k |
EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 166 % | (66 %) | (6 %) | 207 % | 58 % | (26 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
Source: Company filings or news article
Related Content
2Eyes Vision is a technology company specializing in the development and commercialization of ophthalmic technologies. A spin-off from the Spanish National Research Council (CSIC), the company focuses on prevalent eye conditions like presbyopia and cataracts. It was co-founded by Dr. Carlos Dorronsoro, who serves as CEO, and Prof. Dr. Susana Marcos. Dr. Dorronsoro has an extensive background in optical physics and vision science, with experience at CSIC, Leica, and as a co-founder of four spin-off companies. The company is headquartered in Madrid, Spain.
The core product is the SimVis Gekko, a wearable, binocular, see-through visual simulator. This device allows patients to experience their vision with different multifocal corrections before undergoing intraocular lens (IOL) implantation for cataract or refractive surgery. It is not virtual reality; it provides a real-world visual experience through a wide field of view by using fast programmable liquid lenses that simulate various IOL models. The technology aims to reduce patient uncertainty, improve satisfaction with surgical outcomes, and enhance the doctor-patient dialogue. The latest version, SimVis Gekko2, includes a pupil monitoring system for better alignment.
2Eyes Vision's business model is B2B, selling the SimVis Gekko device to ophthalmology clinics and surgeons. The company has an international presence in 18 countries across four continents and works with specialized resellers. It has received regulatory clearance in key markets and operates a scalable manufacturing facility with ISO9001 certification. The technology is supported by over 25 scientific publications and protected by 8 international patent families.
Keywords: visual simulator, ophthalmic technology, presbyopia, cataracts, intraocular lens, SimVis Gekko, medical devices, ophthalmology, see-through display, eye care